文献速递糖尿病

高收入国家不同2型糖尿病诊断年龄相关的预期寿命:2300万人年观察

Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation.
PubMed 文献 · Lancet Diabetes Endocrinol · 2023-09-11

诊断越早全因死亡风险越高,30-39岁诊断HR 2.69,70岁及以上HR 1.39;每提早十年诊断预期寿命约低3-4年。

要点

  • 糖尿病诊断年龄越早,全因死亡风险越高,呈线性剂量反应。
  • 30-39岁诊断HR 2.69,70岁及以上诊断HR 1.39(参照无糖尿病者)。
  • 每提早十年诊断,预期寿命约降低3-4年。

核心结论

  • 每提早十年诊断糖尿病与预期寿命约降低3-4年相关,提示需开发并实施预防或延迟糖尿病发病的干预,并强化年轻成人糖尿病患者的危险因素治疗。

研究设计与样本

  • 观察性研究,合并19个高收入国家个体参与者数据,来源为Emerging Risk Factors Collaboration(96个队列,基线中位年份1961-2007,最新随访中位年份1980-2013)和UK Biobank(基线中位年份2006,最新随访中位年份2020)。

主要发现

  • 与无糖尿病参与者相比,糖尿病患者诊断年龄越早全因死亡风险越高,呈线性剂量反应。
  • 诊断年龄30-39岁HR 2.69(95%CI 2.43-2.97),40-49岁HR 2.26(2.08-2.45),50-59岁HR 1.84(1.72-1.97),60-69岁HR 1.57(1.47-1.67),70岁及以上HR 1.39(1.29-1.51)。
  • 每提早十年诊断的HR在男女中相似。
  • 使用美国2015年死亡率,50岁糖尿病患者若30岁诊断平均比无糖尿病者早死14年,40岁诊断早10年,50岁诊断早6年;使用欧盟死亡率对应估计为13年、9年、5年。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of type 2 diabetes is increasing rapidly, particularly among younger age groups. Estimates suggest that people with diabetes die, on average, 6 years earlier than people without diabetes. We aimed to provide reliable estimates of the associations between age at diagnosis of diabetes and all-cause mortality, cause-specific mortality, and reductions in life expectancy. METHODS: For this observational study, we conducted a combined analysis of individual-participant data from 19 high-income countries using two large-scale data sources: the Emerging Risk Factors Collaboration (96 cohorts, median baseline years 1961-2007, median latest follow-up years 1980-2013) and the UK Biobank (median baseline year 2006, median latest follow-up year 2020). We calculated age-adjusted and sex-adjusted hazard ratios (HRs) for all-cause mortality according to age at diagnosis of diabetes using data from 1 515 718 participants, in whom deaths were recorded during 23·1 million person-years of follow-up. We estimated cumulative survival by applying age-specific HRs to age-specific death rates from 2015 for the USA and the EU. FINDINGS: For participants with diabetes, we observed a linear dose-response association between earlier age at diagnosis and higher risk of all-cause mortality compared with participants without diabetes. HRs were 2·69 (95% CI 2·43-2·97) when diagnosed at 30-39 years, 2·26 (2·08-2·45) at 40-49 years, 1·84 (1·72-1·97) at 50-59 years, 1·57 (1·47-1·67) at 60-69 years, and 1·39 (1·29-1·51) at 70 years and older. HRs per decade of earlier diagnosis were similar for men and women. Using death rates from the USA, a 50-year-old individual with diabetes died on average 14 years earlier when diagnosed aged 30 years, 10 years earlier when diagnosed aged 40 years, or 6 years earlier when diagnosed aged 50 years than an individual without diabetes. Using EU death rates, the corresponding estimates were 13, 9, or 5 years earlier. INTERPRETATION: Every decade of earlier diagnosis of diabetes was associated with about 3-4 years of lower life expectancy, highlighting the need to develop and implement interventions that prevent or delay the onset of diabetes and to intensify the treatment of risk factors among young adults diagnosed with diabetes. FUNDING: British Heart Foundation, Medical Research Council, National Institute for Health and Care Research, and Health Data Research UK.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. Lancet Diabetes Endocrinol. 2023. PMID: 37708900. doi:10.1016/S2213-8587(23)00223-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。